Skip to main content

Gamma 1-heavy chain deposition disease accompanied by IgG kappa in serum, urine, and bone marrow


A 32-year-old Japanese woman presented with hypertension, nephrotic syndrome, microhematuria, and severe hypocomplementemia. Her serum creatinine concentration increased from 1.46 mg/dL (129.0 μmol/L) to 3.46 mg/dL (305.8 μmol/L) over 1 month. Renal biopsy revealed Congo red-negative nodular glomerulosclerosis accompanied by mesangial proliferation. There was extensive staining of immunoglobulin (Ig) G in the glomerular and tubular basement membranes and expanded mesangial regions. Staining was negative for IgA, IgM, and kappa and lambda light chains and positive for the gamma 1 IgG subclass. Staining for constant domains of the gamma heavy chains showed a deletion of the first constant domain (CH1). Electron microscopy revealed electron-dense deposits in the glomerular and tubular basement membranes and mesangium. These findings indicated gamma 1-heavy chain deposition disease (HCDD). Serum and urine immunoelectrophoresis revealed an IgG kappa monoclonal band, whereas bone marrow biopsy revealed monoclonal plasmacytosis with positive staining for kappa chains. HCDD associated with kappa light chain is extremely rare. We report the first case of HCDD with IgG kappa detected in the serum, urine, and bone marrow.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2


  1. Aucouturier P, Khamlichi AA, Touchard G, Justrabo E, Cogne M, Chauffert B, et al. Brief report: heavy-chain deposition disease. N Engl J Med. 1993;329(19):1389–93.

    CAS  PubMed  Article  Google Scholar 

  2. Moulin B, Deret S, Mariette X, Kourilsky O, Imai H, Dupouet L, et al. Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1. J Am Soc Nephrol. 1999;10(3):519–28.

    CAS  PubMed  Google Scholar 

  3. Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol. 2001;12(7):1482–92.

    CAS  PubMed  Google Scholar 

  4. Tubbs RR, Berkley V, Valenzuela R, McMahon JT, Gephardt GN, Fishleder AJ, et al. Pseudo-gamma heavy chain (IgG4 lambda) deposition disease. Mod Pathol. 1992;5(2):185–90.

    CAS  PubMed  Google Scholar 

  5. Katz A, Zent R, Bargman JM. IgG heavy-chain deposition disease. Mod Pathol. 1994;7(8):874–8.

    CAS  PubMed  Google Scholar 

  6. Yasuda T, Fujita K, Imai H, Morita K, Nakamoto Y, Miura AB. Gamma-heavy chain deposition disease showing nodular glomerulosclerosis. Clin Nephrol. 1995;44(6):394–9.

    CAS  PubMed  Google Scholar 

  7. Rott T, Vizjak A, Lindic J, Hvala A, Perkovic T, Cernelc P. IgG heavy-chain deposition disease affecting kidney, skin, and skeletal muscle. Nephrol Dial Transplant. 1998;13(7):1825–8.

    CAS  PubMed  Article  Google Scholar 

  8. Kambham N, Markowitz GS, Appel GB, Kleiner MJ, Aucouturier P, D’Agati VD. Heavy chain deposition disease: the disease spectrum. Am J Kidney Dis. 1999;33(5):954–62.

    CAS  PubMed  Article  Google Scholar 

  9. Ronco P, Plaisier E, Mougenot B, Aucouturier P. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy. Clin J Am Soc Nephrol. 2006;1(6):1342–50.

    CAS  PubMed  Article  Google Scholar 

  10. Herzenberg AM, Kiaii M, Magil AB. Heavy chain deposition disease: recurrence in a renal transplant and report of IgG(2) subtype. Am J Kidney Dis. 2000;35(5):E25.

    CAS  PubMed  Article  Google Scholar 

  11. Herzenberg AM, Lien J, Magil AB. Monoclonal heavy chain (immunoglobulin G3) deposition disease: report of a case. Am J Kidney Dis. 1996;28(1):128–31.

    CAS  PubMed  Article  Google Scholar 

  12. Oe Y, Nakaya I, Yahata M, Sakuma T, Sato H, Soma J. A case of gamma 1-heavy chain deposition disease successfully treated with melphalan and prednisolone therapy. Intern Med. 2010;49(14):1411–5.

    CAS  PubMed  Article  Google Scholar 

  13. Soma J, Sato K, Sakuma T, Saito H, Sato H, Sato T, et al. Immunoglobulin gamma3-heavy-chain deposition disease: report of a case and relationship with hypocomplementemia. Am J Kidney Dis. 2004;43(1):E10–6.

    PubMed  Article  Google Scholar 

  14. Husby G, Blichfeldt P, Brinch L, Brandtzaeg P, Mellbye OJ, Sletten K, et al. Chronic arthritis and gamma heavy chain disease: coincidence or pathogenic link? Scand J Rheumatol. 1998;27(4):257–64.

    CAS  PubMed  Google Scholar 

  15. Vedder AC, Weening JJ, Krediet RT. Intracapillary proliferative glomerulonephritis due to heavy chain deposition disease. Nephrol Dial Transplant. 2004;19(5):1302–4.

    CAS  PubMed  Article  Google Scholar 

  16. Corcos D, Osborn MJ, Matheson LS. B-cell receptors and heavy chain diseases: guilty by association? Blood. 2011;117(26):6991–8.

    CAS  PubMed  Article  Google Scholar 

  17. Roussel A, Spinelli S, Deret S, Navaza J, Aucouturier P, Cambillau C. The structure of an entire noncovalent immunoglobulin kappa light-chain dimer (Bence-Jones protein) reveals a weak and unusual constant domains association. Eur J Biochem. 1999;260(1):192–9.

    CAS  PubMed  Article  Google Scholar 

  18. Ronco PM, Alyanakian MA, Mougenot B, Aucouturier P. Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level. J Am Soc Nephrol. 2001;12(7):1558–65.

    CAS  PubMed  Google Scholar 

  19. Soma J, Tsuchiya Y, Sakuma T, Sato H. Clinical remission and histopathological resolution of nodular lesions in a patient with gamma3 heavy-chain deposition disease. Clin Nephrol. 2008;69(5):383–6.

    CAS  PubMed  Article  Google Scholar 

  20. Tan S, Pon K, Bargman J, Ghazarian D. Generalized cutis laxa associated with heavy chain deposition disease. J Cutan Med Surg. 2003;7(5):390–4.

    PubMed  Article  Google Scholar 

  21. Komatsuda A, Maki N, Wakui H, Ohtani H, Hatakeyama T, Yasuda T, et al. Development of systemic lambda-light chain amyloidosis in a patient with gamma-heavy chain deposition disease during long-term follow-up. Nephrol Dial Transplant. 2005;20(2):434–7.

    PubMed  Article  Google Scholar 

  22. Kastritis E, Migkou M, Gavriatopoulou M, Zirogiannis P, Hadjikonstantinou V, Dimopoulos MA. Treatment of light chain deposition disease with bortezomib and dexamethasone. Haematologica. 2009;94(2):300–2.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

Download references

Conflict of interest

All the authors have declared no competing interest.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Koichi Seta.

About this article

Cite this article

Kaneko, K., Seta, K., Soma, J. et al. Gamma 1-heavy chain deposition disease accompanied by IgG kappa in serum, urine, and bone marrow. CEN Case Rep 3, 44–48 (2014).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • Heavy chain deposition disease
  • Immunoglobulin G1 kappa
  • Hypocomplementemia
  • Plasma cell dyscrasia
  • Renal failure